Why should Cell-based Trivalent Influenza Vaccine Seqirus be administered cautiously to people with thrombocytopenia or a bleeding disorder?

Cell-based Trivalent Influenza Vaccine Seqirus should be administered cautiously to people with thrombocytopenia or a bleeding disorder because bleeding may occur following intramuscular administration.